Targeting DNA Repair

Giuseppe Curigliano1

  • 1Early Drug Development for Innovative Therapy Division, European Institute of Oncology, Via Ripamonti, 435 20141, Milan, Italy. Giuseppe.curigliano@ieo.it.

Summary

Genomic instability drives cancer development and progression. Understanding DNA damage response (DDR) pathways offers new avenues for personalized cancer medicine.